The agent assembled a partial but incomplete answer to the task by accessing the app's HTML root and manifest file, which confirmed it is a seizure-tracking PWA in Hebrew. However, the site's JavaScript-heavy interface, lack of English entry point, absence of public documentation, and no visible pricing or competitive positioning information meant the agent could not fully explain pricing, detailed features, or differentiation from alternatives—it resorted to inference and prior knowledge of competing apps to fill critical gaps.

• ›Steps [1] and [6] returned the raw HTML homepage in Hebrew with RTL layout and data-i18n attributes, confirming the app name ('Appileptic') and basic purpose ('מעקב אירועי אפילפסיה' = seizure event tracking) from the title tag, but the page itself is a SPA shell with no human-readable marketing copy or feature list in static HTML.
• ›Step [10] fetched the manifest.json (discovered from the <link> tag in the HTML), which provided the app's official description in Hebrew and confirmed PWA metadata (Firebase backend, multilingual support via lang tags), but offered no pricing, features, or use-case documentation.
• ›The site publishes NO machine-readable identity layer content (no llms.txt, no meta descriptions in English, no structured data, no FAQ or help section accessible via HTTP). The agent had to rely on search engine results about *competing* seizure apps (Epipal, Epsy, EpiCentr) to infer differentiation, and explicitly stated inability to determine pricing.
• ›An attempted fetch to /en returned 404, confirming there is no English-language version or landing page; the app defaults to Hebrew, creating a discovery and identity barrier for non-Hebrew speakers.
• ›The agent's final answer cites no sources from the site itself—citations point only to competitor apps and a Medical News Today article, indicating the site does not self-document its own value proposition in a way the agent could retrieve and cite.